Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Medgenics Inc.
DescriptionGlucagon-like peptide-2 (GLP-2)
Molecular Target Glucagon-like peptide-2 (GLP-2)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationShort bowel syndrome
Indication DetailsTreat short bowel syndrome (SBS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today